Business Insider

Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure

Participants who lost 24% total body weight (>50 lbs.) on GLP-1 drugs maintained stable weight 6 months after GLP-1 discontinuation and single Revita treatment 1.5% mean weight change observed with ...
Seeking Alpha

New Omada Health Analysis Shows Long-Term Weight Maintenance Post-GLP-1 Discontinuation, Challenging Industry Assumptions

SAN FRANCISCO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Omada Health (OMDA) (Nasdaq: OMDA), the virtual between-visit healthcare provider, released results from a real-world analysis that showed 63% of ...
Nasdaq

Fractyl Health Highlights Urgent Demand for Weight Maintenance Solutions Post-GLP-1 Therapy in Upcoming REMAIN-1 Study Amid Strategic Focus on Metabolic Health

Fractyl Health announces progress in its REMAIN-1 study, focusing on weight maintenance after GLP-1 withdrawal, with key milestones ahead. Fractyl Health, Inc. announced significant progress in its ...
Nasdaq

Fractyl Health and Bariendo Collaborate to Advance Revita for Post-GLP-1 Weight Maintenance Solutions

Fractyl Health and Bariendo Inc. have announced a collaboration to explore the integration of Fractyl's investigational Revita procedure as a weight maintenance solution for patients discontinuing GLP ...